Life Science Company News

Results 1 - 20 out of 500 displayed.
1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »

Basilea announces positive results of phase 3 ERADICATE study with ceftobiprole in Staphylococcus aureus bacteremia (SAB)

Read more ››
By: GlobenewsWire - 28 Jun 2022

Press Release: Nexviadyme® (avalglucosidase alfa) approved by European Commission as a potential new standard of care for the treatment of Pompe Disease

Read more ››
By: GlobenewsWire - 28 Jun 2022

Press Release: Xenpozyme® (olipudase alfa) approved by European Commission as first and only treatment for ASMD

Read more ››
By: GlobenewsWire - 28 Jun 2022

Philips provides update on Philips Respironics’ PE-PUR sound abatement foam test and research program

Read more ››
By: GlobenewsWire - 28 Jun 2022

Bavarian Nordic Announces Grant of PRIME Eligibility from the European Medicines Agency for its RSV Vaccine Candidate for the Prevention of Respiratory Syncytial Virus in Older Adults

Read more ››
By: GlobenewsWire - 28 Jun 2022

6,214 Orion Corporation A shares converted into B shares

Read more ››
By: GlobenewsWire - 28 Jun 2022

MRM Health Starts Clinical Trial with Next-Generation Optimized Consortium Therapeutic MH002 in Pouchitis

Read more ››
By: GlobenewsWire - 28 Jun 2022

Mainz Biomed Enrolls First Patient in ColoFuture Study Evaluating Integration of Novel mRNA Biomarkers into ColoAlert

Read more ››
By: GlobenewsWire - 28 Jun 2022

Orion publishes Half-Year Financial Report for January–June 2022 on Friday 15 July 2022

Read more ››
By: GlobenewsWire - 28 Jun 2022

Roivant and Pfizer Unveil Priovant Therapeutics and Ongoing Registrational Studies for Oral Brepocitinib in Dermatomyositis and Lupus

Read more ››
By: GlobenewsWire - 28 Jun 2022

P-Cure to support Hadassah Medical Organization in being the first to provide Proton Therapy to cancer patients in Israel

Read more ››
By: PR Newswire Association LLC. - 28 Jun 2022

Ascletis Announced First Subject Dosed in the Phase II Clinical Trial of ASC22 (Envafolimab) for Immune Restoration/ Functional Cure of HIV-1 Infection

Read more ››
By: PR Newswire Association LLC. - 28 Jun 2022

Can4Med Announces First Shipment of Medical Grade Cannabis for Distribution in Poland

Read more ››
By: PR Newswire Association LLC. - 28 Jun 2022

Valued to be $1.8 Billion by 2026, Cardiac Surgery Instruments Slated for Robust Growth Worldwide

Read more ››
By: PR Newswire Association LLC. - 28 Jun 2022

A $607 Million Global Opportunity for Cardiopulmonary Autotransfusion Systems by 2026 - New Research from StrategyR

Read more ››
By: PR Newswire Association LLC. - 28 Jun 2022

ClariGenZ Reveals How BioCitroid Is Taking The World By Storm

Read more ››
By: PR Newswire Association LLC. - 28 Jun 2022

IDEAYA Announces Development Candidate Nomination of a Potential First-in-Class Pol Theta Helicase Inhibitor in Collaboration with GSK

Read more ››
By: PR Newswire Association LLC. - 28 Jun 2022

Kindle FREE June 28-29: Powerful new memoir from Santa Molina-Marshall poised to help heal abuse victims through inspiring storytelling

Read more ››
By: PR Newswire Association LLC. - 28 Jun 2022

U.S. Government to support expansion of Croda lipid systems capability

Read more ››
By: PR Newswire Association LLC. - 28 Jun 2022

New CRISPR/Cas9 license agreement for ERS Genomics and Cytosurge

Read more ››
By: PR Newswire Association LLC. - 28 Jun 2022
Results 1 - 20 out of 500 displayed.
1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »

Enhance your business development with Biotechgate